nodes	percent_of_prediction	percent_of_DWPC	metapath
Remifentanil—Sufentanil—CYP3A4—breast cancer	0.00171	0.185	CrCbGaD
Remifentanil—Alfentanil—CYP3A4—breast cancer	0.00159	0.172	CrCbGaD
Remifentanil—Alfentanil—ALB—breast cancer	0.00139	0.15	CrCbGaD
Remifentanil—Alfentanil—ABCB1—breast cancer	0.00132	0.143	CrCbGaD
Remifentanil—Pethidine—CYP2D6—breast cancer	0.000835	0.0903	CrCbGaD
Remifentanil—Pethidine—CYP3A4—breast cancer	0.000717	0.0774	CrCbGaD
Remifentanil—Pethidine—ALB—breast cancer	0.000625	0.0675	CrCbGaD
Remifentanil—Fentanyl—CYP3A4—breast cancer	0.000582	0.0629	CrCbGaD
Remifentanil—Fentanyl—ABCB1—breast cancer	0.000485	0.0524	CrCbGaD
Remifentanil—Gastrointestinal disorder—Paclitaxel—breast cancer	0.000262	0.000325	CcSEcCtD
Remifentanil—Haemorrhage—Methotrexate—breast cancer	0.000261	0.000323	CcSEcCtD
Remifentanil—Sweating—Epirubicin—breast cancer	0.000261	0.000323	CcSEcCtD
Remifentanil—Pain—Paclitaxel—breast cancer	0.00026	0.000322	CcSEcCtD
Remifentanil—Constipation—Paclitaxel—breast cancer	0.00026	0.000322	CcSEcCtD
Remifentanil—Haematuria—Epirubicin—breast cancer	0.00026	0.000322	CcSEcCtD
Remifentanil—Confusional state—Docetaxel—breast cancer	0.00026	0.000322	CcSEcCtD
Remifentanil—Pharyngitis—Methotrexate—breast cancer	0.000259	0.000321	CcSEcCtD
Remifentanil—Anxiety—Capecitabine—breast cancer	0.000259	0.000321	CcSEcCtD
Remifentanil—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—breast cancer	0.000258	0.00032	CcSEcCtD
Remifentanil—Oedema—Docetaxel—breast cancer	0.000257	0.000319	CcSEcCtD
Remifentanil—Anaphylactic shock—Docetaxel—breast cancer	0.000257	0.000319	CcSEcCtD
Remifentanil—Pruritus—Gemcitabine—breast cancer	0.000257	0.000318	CcSEcCtD
Remifentanil—Nausea—Thiotepa—breast cancer	0.000256	0.000317	CcSEcCtD
Remifentanil—Hyperglycaemia—Doxorubicin—breast cancer	0.000255	0.000316	CcSEcCtD
Remifentanil—Diarrhoea—Mitoxantrone—breast cancer	0.000255	0.000316	CcSEcCtD
Remifentanil—Diarrhoea—Irinotecan—breast cancer	0.000255	0.000316	CcSEcCtD
Remifentanil—Dry mouth—Capecitabine—breast cancer	0.000254	0.000315	CcSEcCtD
Remifentanil—Pneumonia—Doxorubicin—breast cancer	0.000253	0.000314	CcSEcCtD
Remifentanil—Shock—Docetaxel—breast cancer	0.000253	0.000314	CcSEcCtD
Remifentanil—Nervous system disorder—Docetaxel—breast cancer	0.000253	0.000313	CcSEcCtD
Remifentanil—Pruritus—Fluorouracil—breast cancer	0.000252	0.000313	CcSEcCtD
Remifentanil—Thrombocytopenia—Docetaxel—breast cancer	0.000252	0.000312	CcSEcCtD
Remifentanil—Visual impairment—Methotrexate—breast cancer	0.000252	0.000312	CcSEcCtD
Remifentanil—Confusional state—Capecitabine—breast cancer	0.000251	0.000311	CcSEcCtD
Remifentanil—Tachycardia—Docetaxel—breast cancer	0.000251	0.000311	CcSEcCtD
Remifentanil—Feeling abnormal—Paclitaxel—breast cancer	0.00025	0.00031	CcSEcCtD
Remifentanil—Skin disorder—Docetaxel—breast cancer	0.00025	0.00031	CcSEcCtD
Remifentanil—Oedema—Capecitabine—breast cancer	0.000249	0.000309	CcSEcCtD
Remifentanil—Bradycardia—Epirubicin—breast cancer	0.000249	0.000308	CcSEcCtD
Remifentanil—Diarrhoea—Gemcitabine—breast cancer	0.000248	0.000307	CcSEcCtD
Remifentanil—Renal failure—Doxorubicin—breast cancer	0.000248	0.000307	CcSEcCtD
Remifentanil—Dizziness—Irinotecan—breast cancer	0.000246	0.000305	CcSEcCtD
Remifentanil—Haemoglobin—Epirubicin—breast cancer	0.000246	0.000304	CcSEcCtD
Remifentanil—Shock—Capecitabine—breast cancer	0.000245	0.000304	CcSEcCtD
Remifentanil—Nervous system disorder—Capecitabine—breast cancer	0.000244	0.000303	CcSEcCtD
Remifentanil—Haemorrhage—Epirubicin—breast cancer	0.000244	0.000303	CcSEcCtD
Remifentanil—Diarrhoea—Fluorouracil—breast cancer	0.000244	0.000302	CcSEcCtD
Remifentanil—Thrombocytopenia—Capecitabine—breast cancer	0.000244	0.000302	CcSEcCtD
Remifentanil—Tachycardia—Capecitabine—breast cancer	0.000243	0.000301	CcSEcCtD
Remifentanil—Pharyngitis—Epirubicin—breast cancer	0.000243	0.0003	CcSEcCtD
Remifentanil—Cardiac disorder—Methotrexate—breast cancer	0.000242	0.0003	CcSEcCtD
Remifentanil—Skin disorder—Capecitabine—breast cancer	0.000242	0.0003	CcSEcCtD
Remifentanil—Sweating—Doxorubicin—breast cancer	0.000242	0.000299	CcSEcCtD
Remifentanil—Urticaria—Paclitaxel—breast cancer	0.000241	0.000299	CcSEcCtD
Remifentanil—Hyperhidrosis—Capecitabine—breast cancer	0.000241	0.000298	CcSEcCtD
Remifentanil—Hypotension—Docetaxel—breast cancer	0.000241	0.000298	CcSEcCtD
Remifentanil—Haematuria—Doxorubicin—breast cancer	0.00024	0.000297	CcSEcCtD
Remifentanil—Body temperature increased—Paclitaxel—breast cancer	0.00024	0.000297	CcSEcCtD
Remifentanil—Angiopathy—Methotrexate—breast cancer	0.000237	0.000293	CcSEcCtD
Remifentanil—Vomiting—Irinotecan—breast cancer	0.000237	0.000293	CcSEcCtD
Remifentanil—Vomiting—Mitoxantrone—breast cancer	0.000237	0.000293	CcSEcCtD
Remifentanil—Immune system disorder—Methotrexate—breast cancer	0.000236	0.000292	CcSEcCtD
Remifentanil—Dizziness—Fluorouracil—breast cancer	0.000236	0.000292	CcSEcCtD
Remifentanil—Visual impairment—Epirubicin—breast cancer	0.000236	0.000292	CcSEcCtD
Remifentanil—Mediastinal disorder—Methotrexate—breast cancer	0.000235	0.000292	CcSEcCtD
Remifentanil—Rash—Irinotecan—breast cancer	0.000235	0.000291	CcSEcCtD
Remifentanil—Rash—Mitoxantrone—breast cancer	0.000235	0.000291	CcSEcCtD
Remifentanil—Dermatitis—Irinotecan—breast cancer	0.000235	0.000291	CcSEcCtD
Remifentanil—Dermatitis—Mitoxantrone—breast cancer	0.000235	0.000291	CcSEcCtD
Remifentanil—Chills—Methotrexate—breast cancer	0.000234	0.00029	CcSEcCtD
Remifentanil—Headache—Irinotecan—breast cancer	0.000233	0.000289	CcSEcCtD
Remifentanil—Headache—Mitoxantrone—breast cancer	0.000233	0.000289	CcSEcCtD
Remifentanil—Hypotension—Capecitabine—breast cancer	0.000233	0.000288	CcSEcCtD
Remifentanil—Paraesthesia—Docetaxel—breast cancer	0.000231	0.000286	CcSEcCtD
Remifentanil—Vomiting—Gemcitabine—breast cancer	0.000231	0.000286	CcSEcCtD
Remifentanil—Bradycardia—Doxorubicin—breast cancer	0.00023	0.000285	CcSEcCtD
Remifentanil—Dyspnoea—Docetaxel—breast cancer	0.00023	0.000284	CcSEcCtD
Remifentanil—Somnolence—Docetaxel—breast cancer	0.000229	0.000283	CcSEcCtD
Remifentanil—Rash—Gemcitabine—breast cancer	0.000229	0.000283	CcSEcCtD
Remifentanil—Dermatitis—Gemcitabine—breast cancer	0.000229	0.000283	CcSEcCtD
Remifentanil—Erythema—Methotrexate—breast cancer	0.000227	0.000282	CcSEcCtD
Remifentanil—Haemoglobin—Doxorubicin—breast cancer	0.000227	0.000282	CcSEcCtD
Remifentanil—Headache—Gemcitabine—breast cancer	0.000227	0.000281	CcSEcCtD
Remifentanil—Cardiac disorder—Epirubicin—breast cancer	0.000227	0.000281	CcSEcCtD
Remifentanil—Flushing—Epirubicin—breast cancer	0.000227	0.000281	CcSEcCtD
Remifentanil—Vomiting—Fluorouracil—breast cancer	0.000227	0.000281	CcSEcCtD
Remifentanil—Dyspepsia—Docetaxel—breast cancer	0.000227	0.000281	CcSEcCtD
Remifentanil—Haemorrhage—Doxorubicin—breast cancer	0.000226	0.00028	CcSEcCtD
Remifentanil—Rash—Fluorouracil—breast cancer	0.000225	0.000279	CcSEcCtD
Remifentanil—Dermatitis—Fluorouracil—breast cancer	0.000225	0.000278	CcSEcCtD
Remifentanil—Pharyngitis—Doxorubicin—breast cancer	0.000224	0.000278	CcSEcCtD
Remifentanil—Paraesthesia—Capecitabine—breast cancer	0.000224	0.000277	CcSEcCtD
Remifentanil—Hypersensitivity—Paclitaxel—breast cancer	0.000224	0.000277	CcSEcCtD
Remifentanil—Headache—Fluorouracil—breast cancer	0.000223	0.000277	CcSEcCtD
Remifentanil—Gastrointestinal disorder—Docetaxel—breast cancer	0.000222	0.000275	CcSEcCtD
Remifentanil—Dyspnoea—Capecitabine—breast cancer	0.000222	0.000275	CcSEcCtD
Remifentanil—Angiopathy—Epirubicin—breast cancer	0.000222	0.000275	CcSEcCtD
Remifentanil—Nausea—Irinotecan—breast cancer	0.000221	0.000274	CcSEcCtD
Remifentanil—Nausea—Mitoxantrone—breast cancer	0.000221	0.000274	CcSEcCtD
Remifentanil—Immune system disorder—Epirubicin—breast cancer	0.000221	0.000273	CcSEcCtD
Remifentanil—Mediastinal disorder—Epirubicin—breast cancer	0.00022	0.000273	CcSEcCtD
Remifentanil—Pain—Docetaxel—breast cancer	0.00022	0.000273	CcSEcCtD
Remifentanil—Constipation—Docetaxel—breast cancer	0.00022	0.000273	CcSEcCtD
Remifentanil—Dyspepsia—Capecitabine—breast cancer	0.000219	0.000272	CcSEcCtD
Remifentanil—Chills—Epirubicin—breast cancer	0.000219	0.000272	CcSEcCtD
Remifentanil—Arrhythmia—Epirubicin—breast cancer	0.000218	0.00027	CcSEcCtD
Remifentanil—Visual impairment—Doxorubicin—breast cancer	0.000218	0.00027	CcSEcCtD
Remifentanil—Nausea—Gemcitabine—breast cancer	0.000216	0.000267	CcSEcCtD
Remifentanil—Gastrointestinal disorder—Capecitabine—breast cancer	0.000215	0.000267	CcSEcCtD
Remifentanil—Pruritus—Paclitaxel—breast cancer	0.000215	0.000266	CcSEcCtD
Remifentanil—Pain—Capecitabine—breast cancer	0.000213	0.000264	CcSEcCtD
Remifentanil—Constipation—Capecitabine—breast cancer	0.000213	0.000264	CcSEcCtD
Remifentanil—Erythema—Epirubicin—breast cancer	0.000213	0.000264	CcSEcCtD
Remifentanil—Feeling abnormal—Docetaxel—breast cancer	0.000212	0.000263	CcSEcCtD
Remifentanil—Nausea—Fluorouracil—breast cancer	0.000212	0.000262	CcSEcCtD
Remifentanil—Anaemia—Methotrexate—breast cancer	0.00021	0.00026	CcSEcCtD
Remifentanil—Cardiac disorder—Doxorubicin—breast cancer	0.00021	0.00026	CcSEcCtD
Remifentanil—Flushing—Doxorubicin—breast cancer	0.00021	0.00026	CcSEcCtD
Remifentanil—Diarrhoea—Paclitaxel—breast cancer	0.000208	0.000257	CcSEcCtD
Remifentanil—Feeling abnormal—Capecitabine—breast cancer	0.000205	0.000254	CcSEcCtD
Remifentanil—Angiopathy—Doxorubicin—breast cancer	0.000205	0.000254	CcSEcCtD
Remifentanil—Immune system disorder—Doxorubicin—breast cancer	0.000204	0.000253	CcSEcCtD
Remifentanil—Mediastinal disorder—Doxorubicin—breast cancer	0.000204	0.000252	CcSEcCtD
Remifentanil—Body temperature increased—Docetaxel—breast cancer	0.000204	0.000252	CcSEcCtD
Remifentanil—Chills—Doxorubicin—breast cancer	0.000203	0.000251	CcSEcCtD
Remifentanil—Arrhythmia—Doxorubicin—breast cancer	0.000202	0.00025	CcSEcCtD
Remifentanil—Dizziness—Paclitaxel—breast cancer	0.000201	0.000249	CcSEcCtD
Remifentanil—Cough—Methotrexate—breast cancer	0.000198	0.000246	CcSEcCtD
Remifentanil—Urticaria—Capecitabine—breast cancer	0.000198	0.000245	CcSEcCtD
Remifentanil—Body temperature increased—Capecitabine—breast cancer	0.000197	0.000244	CcSEcCtD
Remifentanil—Convulsion—Methotrexate—breast cancer	0.000197	0.000244	CcSEcCtD
Remifentanil—Erythema—Doxorubicin—breast cancer	0.000197	0.000244	CcSEcCtD
Remifentanil—Anaemia—Epirubicin—breast cancer	0.000197	0.000244	CcSEcCtD
Remifentanil—Agitation—Epirubicin—breast cancer	0.000196	0.000242	CcSEcCtD
Remifentanil—Vomiting—Paclitaxel—breast cancer	0.000193	0.000239	CcSEcCtD
Remifentanil—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—breast cancer	0.000192	0.000238	CcSEcCtD
Remifentanil—Rash—Paclitaxel—breast cancer	0.000192	0.000237	CcSEcCtD
Remifentanil—Dermatitis—Paclitaxel—breast cancer	0.000191	0.000237	CcSEcCtD
Remifentanil—Syncope—Epirubicin—breast cancer	0.000191	0.000236	CcSEcCtD
Remifentanil—Headache—Paclitaxel—breast cancer	0.00019	0.000236	CcSEcCtD
Remifentanil—Hypersensitivity—Docetaxel—breast cancer	0.00019	0.000235	CcSEcCtD
Remifentanil—Confusional state—Methotrexate—breast cancer	0.000187	0.000232	CcSEcCtD
Remifentanil—Loss of consciousness—Epirubicin—breast cancer	0.000187	0.000232	CcSEcCtD
Remifentanil—Cough—Epirubicin—breast cancer	0.000186	0.00023	CcSEcCtD
Remifentanil—Anaphylactic shock—Methotrexate—breast cancer	0.000186	0.00023	CcSEcCtD
Remifentanil—Convulsion—Epirubicin—breast cancer	0.000184	0.000228	CcSEcCtD
Remifentanil—Hypertension—Epirubicin—breast cancer	0.000184	0.000228	CcSEcCtD
Remifentanil—Hypersensitivity—Capecitabine—breast cancer	0.000184	0.000227	CcSEcCtD
Remifentanil—Pruritus—Docetaxel—breast cancer	0.000182	0.000226	CcSEcCtD
Remifentanil—Nervous system disorder—Methotrexate—breast cancer	0.000182	0.000225	CcSEcCtD
Remifentanil—Anaemia—Doxorubicin—breast cancer	0.000182	0.000225	CcSEcCtD
Remifentanil—Thrombocytopenia—Methotrexate—breast cancer	0.000182	0.000225	CcSEcCtD
Remifentanil—Agitation—Doxorubicin—breast cancer	0.000181	0.000224	CcSEcCtD
Remifentanil—Anxiety—Epirubicin—breast cancer	0.000181	0.000224	CcSEcCtD
Remifentanil—Nausea—Paclitaxel—breast cancer	0.00018	0.000223	CcSEcCtD
Remifentanil—Skin disorder—Methotrexate—breast cancer	0.00018	0.000223	CcSEcCtD
Remifentanil—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—breast cancer	0.00018	0.000223	CcSEcCtD
Remifentanil—Hyperhidrosis—Methotrexate—breast cancer	0.000179	0.000222	CcSEcCtD
Remifentanil—Dry mouth—Epirubicin—breast cancer	0.000177	0.000219	CcSEcCtD
Remifentanil—Syncope—Doxorubicin—breast cancer	0.000177	0.000219	CcSEcCtD
Remifentanil—Pruritus—Capecitabine—breast cancer	0.000176	0.000218	CcSEcCtD
Remifentanil—Diarrhoea—Docetaxel—breast cancer	0.000176	0.000218	CcSEcCtD
Remifentanil—Confusional state—Epirubicin—breast cancer	0.000175	0.000217	CcSEcCtD
Remifentanil—Anaphylactic shock—Epirubicin—breast cancer	0.000174	0.000215	CcSEcCtD
Remifentanil—Oedema—Epirubicin—breast cancer	0.000174	0.000215	CcSEcCtD
Remifentanil—Hypotension—Methotrexate—breast cancer	0.000173	0.000215	CcSEcCtD
Remifentanil—Loss of consciousness—Doxorubicin—breast cancer	0.000173	0.000214	CcSEcCtD
Remifentanil—Cough—Doxorubicin—breast cancer	0.000172	0.000213	CcSEcCtD
Remifentanil—Shock—Epirubicin—breast cancer	0.000171	0.000212	CcSEcCtD
Remifentanil—Convulsion—Doxorubicin—breast cancer	0.000171	0.000211	CcSEcCtD
Remifentanil—Diarrhoea—Capecitabine—breast cancer	0.000171	0.000211	CcSEcCtD
Remifentanil—Nervous system disorder—Epirubicin—breast cancer	0.00017	0.000211	CcSEcCtD
Remifentanil—Dizziness—Docetaxel—breast cancer	0.00017	0.000211	CcSEcCtD
Remifentanil—Thrombocytopenia—Epirubicin—breast cancer	0.00017	0.000211	CcSEcCtD
Remifentanil—Hypertension—Doxorubicin—breast cancer	0.00017	0.000211	CcSEcCtD
Remifentanil—Tachycardia—Epirubicin—breast cancer	0.000169	0.00021	CcSEcCtD
Remifentanil—Skin disorder—Epirubicin—breast cancer	0.000169	0.000209	CcSEcCtD
Remifentanil—Hyperhidrosis—Epirubicin—breast cancer	0.000168	0.000208	CcSEcCtD
Remifentanil—Anxiety—Doxorubicin—breast cancer	0.000167	0.000207	CcSEcCtD
Remifentanil—Paraesthesia—Methotrexate—breast cancer	0.000167	0.000206	CcSEcCtD
Remifentanil—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—breast cancer	0.000166	0.000206	CcSEcCtD
Remifentanil—Dyspnoea—Methotrexate—breast cancer	0.000165	0.000205	CcSEcCtD
Remifentanil—Somnolence—Methotrexate—breast cancer	0.000165	0.000204	CcSEcCtD
Remifentanil—Dizziness—Capecitabine—breast cancer	0.000165	0.000204	CcSEcCtD
Remifentanil—Dry mouth—Doxorubicin—breast cancer	0.000164	0.000203	CcSEcCtD
Remifentanil—Vomiting—Docetaxel—breast cancer	0.000164	0.000203	CcSEcCtD
Remifentanil—Dyspepsia—Methotrexate—breast cancer	0.000163	0.000202	CcSEcCtD
Remifentanil—Rash—Docetaxel—breast cancer	0.000162	0.000201	CcSEcCtD
Remifentanil—Hypotension—Epirubicin—breast cancer	0.000162	0.000201	CcSEcCtD
Remifentanil—Dermatitis—Docetaxel—breast cancer	0.000162	0.000201	CcSEcCtD
Remifentanil—Confusional state—Doxorubicin—breast cancer	0.000162	0.000201	CcSEcCtD
Remifentanil—Headache—Docetaxel—breast cancer	0.000161	0.0002	CcSEcCtD
Remifentanil—Anaphylactic shock—Doxorubicin—breast cancer	0.000161	0.000199	CcSEcCtD
Remifentanil—Oedema—Doxorubicin—breast cancer	0.000161	0.000199	CcSEcCtD
Remifentanil—Gastrointestinal disorder—Methotrexate—breast cancer	0.00016	0.000198	CcSEcCtD
Remifentanil—Pain—Methotrexate—breast cancer	0.000159	0.000197	CcSEcCtD
Remifentanil—Vomiting—Capecitabine—breast cancer	0.000158	0.000196	CcSEcCtD
Remifentanil—Shock—Doxorubicin—breast cancer	0.000158	0.000196	CcSEcCtD
Remifentanil—Nervous system disorder—Doxorubicin—breast cancer	0.000158	0.000195	CcSEcCtD
Remifentanil—Thrombocytopenia—Doxorubicin—breast cancer	0.000157	0.000195	CcSEcCtD
Remifentanil—Rash—Capecitabine—breast cancer	0.000157	0.000195	CcSEcCtD
Remifentanil—Dermatitis—Capecitabine—breast cancer	0.000157	0.000194	CcSEcCtD
Remifentanil—Tachycardia—Doxorubicin—breast cancer	0.000157	0.000194	CcSEcCtD
Remifentanil—Headache—Capecitabine—breast cancer	0.000156	0.000193	CcSEcCtD
Remifentanil—Skin disorder—Doxorubicin—breast cancer	0.000156	0.000193	CcSEcCtD
Remifentanil—Paraesthesia—Epirubicin—breast cancer	0.000156	0.000193	CcSEcCtD
Remifentanil—Hyperhidrosis—Doxorubicin—breast cancer	0.000155	0.000192	CcSEcCtD
Remifentanil—Dyspnoea—Epirubicin—breast cancer	0.000155	0.000192	CcSEcCtD
Remifentanil—Somnolence—Epirubicin—breast cancer	0.000154	0.000191	CcSEcCtD
Remifentanil—Nausea—Docetaxel—breast cancer	0.000153	0.000189	CcSEcCtD
Remifentanil—Feeling abnormal—Methotrexate—breast cancer	0.000153	0.000189	CcSEcCtD
Remifentanil—Dyspepsia—Epirubicin—breast cancer	0.000153	0.000189	CcSEcCtD
Remifentanil—Hypotension—Doxorubicin—breast cancer	0.00015	0.000186	CcSEcCtD
Remifentanil—Gastrointestinal disorder—Epirubicin—breast cancer	0.00015	0.000186	CcSEcCtD
Remifentanil—Pain—Epirubicin—breast cancer	0.000149	0.000184	CcSEcCtD
Remifentanil—Constipation—Epirubicin—breast cancer	0.000149	0.000184	CcSEcCtD
Remifentanil—Nausea—Capecitabine—breast cancer	0.000148	0.000183	CcSEcCtD
Remifentanil—Urticaria—Methotrexate—breast cancer	0.000147	0.000183	CcSEcCtD
Remifentanil—Body temperature increased—Methotrexate—breast cancer	0.000147	0.000182	CcSEcCtD
Remifentanil—Paraesthesia—Doxorubicin—breast cancer	0.000144	0.000179	CcSEcCtD
Remifentanil—Dyspnoea—Doxorubicin—breast cancer	0.000143	0.000177	CcSEcCtD
Remifentanil—Feeling abnormal—Epirubicin—breast cancer	0.000143	0.000177	CcSEcCtD
Remifentanil—Somnolence—Doxorubicin—breast cancer	0.000143	0.000177	CcSEcCtD
Remifentanil—Dyspepsia—Doxorubicin—breast cancer	0.000141	0.000175	CcSEcCtD
Remifentanil—Gastrointestinal disorder—Doxorubicin—breast cancer	0.000139	0.000172	CcSEcCtD
Remifentanil—Urticaria—Epirubicin—breast cancer	0.000138	0.000171	CcSEcCtD
Remifentanil—Pain—Doxorubicin—breast cancer	0.000137	0.00017	CcSEcCtD
Remifentanil—Constipation—Doxorubicin—breast cancer	0.000137	0.00017	CcSEcCtD
Remifentanil—Body temperature increased—Epirubicin—breast cancer	0.000137	0.00017	CcSEcCtD
Remifentanil—Hypersensitivity—Methotrexate—breast cancer	0.000137	0.000169	CcSEcCtD
Remifentanil—Feeling abnormal—Doxorubicin—breast cancer	0.000132	0.000164	CcSEcCtD
Remifentanil—Pruritus—Methotrexate—breast cancer	0.000131	0.000163	CcSEcCtD
Remifentanil—Hypersensitivity—Epirubicin—breast cancer	0.000128	0.000158	CcSEcCtD
Remifentanil—Urticaria—Doxorubicin—breast cancer	0.000128	0.000158	CcSEcCtD
Remifentanil—Body temperature increased—Doxorubicin—breast cancer	0.000127	0.000157	CcSEcCtD
Remifentanil—Diarrhoea—Methotrexate—breast cancer	0.000127	0.000157	CcSEcCtD
Remifentanil—Pruritus—Epirubicin—breast cancer	0.000123	0.000152	CcSEcCtD
Remifentanil—Dizziness—Methotrexate—breast cancer	0.000123	0.000152	CcSEcCtD
Remifentanil—Diarrhoea—Epirubicin—breast cancer	0.000119	0.000147	CcSEcCtD
Remifentanil—Hypersensitivity—Doxorubicin—breast cancer	0.000118	0.000147	CcSEcCtD
Remifentanil—Vomiting—Methotrexate—breast cancer	0.000118	0.000146	CcSEcCtD
Remifentanil—Rash—Methotrexate—breast cancer	0.000117	0.000145	CcSEcCtD
Remifentanil—Dermatitis—Methotrexate—breast cancer	0.000117	0.000145	CcSEcCtD
Remifentanil—Headache—Methotrexate—breast cancer	0.000116	0.000144	CcSEcCtD
Remifentanil—Dizziness—Epirubicin—breast cancer	0.000115	0.000142	CcSEcCtD
Remifentanil—Pruritus—Doxorubicin—breast cancer	0.000114	0.000141	CcSEcCtD
Remifentanil—Vomiting—Epirubicin—breast cancer	0.00011	0.000137	CcSEcCtD
Remifentanil—Nausea—Methotrexate—breast cancer	0.00011	0.000137	CcSEcCtD
Remifentanil—Diarrhoea—Doxorubicin—breast cancer	0.00011	0.000136	CcSEcCtD
Remifentanil—Rash—Epirubicin—breast cancer	0.00011	0.000136	CcSEcCtD
Remifentanil—Dermatitis—Epirubicin—breast cancer	0.000109	0.000135	CcSEcCtD
Remifentanil—Headache—Epirubicin—breast cancer	0.000109	0.000135	CcSEcCtD
Remifentanil—Dizziness—Doxorubicin—breast cancer	0.000106	0.000132	CcSEcCtD
Remifentanil—Nausea—Epirubicin—breast cancer	0.000103	0.000128	CcSEcCtD
Remifentanil—Vomiting—Doxorubicin—breast cancer	0.000102	0.000127	CcSEcCtD
Remifentanil—Rash—Doxorubicin—breast cancer	0.000101	0.000125	CcSEcCtD
Remifentanil—Dermatitis—Doxorubicin—breast cancer	0.000101	0.000125	CcSEcCtD
Remifentanil—Headache—Doxorubicin—breast cancer	0.000101	0.000125	CcSEcCtD
Remifentanil—Nausea—Doxorubicin—breast cancer	9.54e-05	0.000118	CcSEcCtD
Remifentanil—OPRD1—Signaling Pathways—E2F1—breast cancer	5.48e-05	0.000299	CbGpPWpGaD
Remifentanil—OPRD1—Signaling by GPCR—PIK3CB—breast cancer	5.45e-05	0.000297	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—PAK1—breast cancer	5.43e-05	0.000296	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—TGFBR2—breast cancer	5.4e-05	0.000295	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—TCF7L2—breast cancer	5.34e-05	0.000291	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—ITPR1—breast cancer	5.31e-05	0.00029	CbGpPWpGaD
Remifentanil—OPRM1—GPCR downstream signaling—AKT2—breast cancer	5.31e-05	0.00029	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—ERBB4—breast cancer	5.28e-05	0.000288	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—STAT5A—breast cancer	5.28e-05	0.000288	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—MMP3—breast cancer	5.28e-05	0.000288	CbGpPWpGaD
Remifentanil—OPRM1—Signaling by GPCR—PIK3CG—breast cancer	5.27e-05	0.000288	CbGpPWpGaD
Remifentanil—OPRK1—GPCR downstream signaling—PIK3CB—breast cancer	5.26e-05	0.000287	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—SPP1—breast cancer	5.26e-05	0.000287	CbGpPWpGaD
Remifentanil—OPRD1—Signaling by GPCR—CXCL8—breast cancer	5.24e-05	0.000286	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—ERBB3—breast cancer	5.2e-05	0.000284	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—FGFR2—breast cancer	5.2e-05	0.000284	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—HSP90AA1—breast cancer	5.14e-05	0.000281	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—NOTCH2—breast cancer	5.14e-05	0.000281	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—SMAD4—breast cancer	5.11e-05	0.000279	CbGpPWpGaD
Remifentanil—OPRM1—GPCR downstream signaling—PIK3CD—breast cancer	5.1e-05	0.000278	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—IGF1R—breast cancer	5.08e-05	0.000277	CbGpPWpGaD
Remifentanil—OPRK1—GPCR downstream signaling—CXCL8—breast cancer	5.06e-05	0.000276	CbGpPWpGaD
Remifentanil—OPRD1—Signaling by GPCR—IL2—breast cancer	5.01e-05	0.000273	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—AGTR1—breast cancer	5e-05	0.000273	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—PRL—breast cancer	5e-05	0.000273	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—HES1—breast cancer	4.99e-05	0.000272	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—TERT—breast cancer	4.99e-05	0.000272	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—PLA2G4A—breast cancer	4.96e-05	0.000271	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—NCOR1—breast cancer	4.96e-05	0.000271	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—ADAM10—breast cancer	4.93e-05	0.000269	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—STK11—breast cancer	4.93e-05	0.000269	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—CSF2—breast cancer	4.91e-05	0.000268	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—FGF1—breast cancer	4.91e-05	0.000268	CbGpPWpGaD
Remifentanil—OPRK1—Signaling by GPCR—RAF1—breast cancer	4.9e-05	0.000267	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—PLG—breast cancer	4.88e-05	0.000266	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—NRG1—breast cancer	4.87e-05	0.000266	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—FGFR1—breast cancer	4.84e-05	0.000264	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—H2AFX—breast cancer	4.84e-05	0.000264	CbGpPWpGaD
Remifentanil—OPRK1—GPCR downstream signaling—IL2—breast cancer	4.83e-05	0.000264	CbGpPWpGaD
Remifentanil—OPRM1—Signaling by GPCR—AKT2—breast cancer	4.82e-05	0.000263	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—E2F1—breast cancer	4.8e-05	0.000262	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—FGF10—breast cancer	4.8e-05	0.000262	CbGpPWpGaD
Remifentanil—OPRK1—Signaling by GPCR—PIK3CB—breast cancer	4.78e-05	0.000261	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—HIF1A—breast cancer	4.77e-05	0.00026	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—LEP—breast cancer	4.66e-05	0.000254	CbGpPWpGaD
Remifentanil—OPRM1—Signaling by GPCR—PIK3CD—breast cancer	4.63e-05	0.000253	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—PDGFA—breast cancer	4.63e-05	0.000253	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—CAV1—breast cancer	4.61e-05	0.000252	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—SPP1—breast cancer	4.61e-05	0.000252	CbGpPWpGaD
Remifentanil—OPRK1—Signaling by GPCR—CXCL8—breast cancer	4.59e-05	0.000251	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—TGFBR2—breast cancer	4.56e-05	0.000249	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—ERBB3—breast cancer	4.56e-05	0.000249	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—KDR—breast cancer	4.56e-05	0.000249	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—FGFR2—breast cancer	4.56e-05	0.000249	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—ITPR1—breast cancer	4.49e-05	0.000245	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—MMP3—breast cancer	4.46e-05	0.000243	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—ERBB4—breast cancer	4.46e-05	0.000243	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—STAT5A—breast cancer	4.46e-05	0.000243	CbGpPWpGaD
Remifentanil—OPRM1—GPCR downstream signaling—PIK3CB—breast cancer	4.45e-05	0.000243	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—ESR1—breast cancer	4.45e-05	0.000243	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—FN1—breast cancer	4.39e-05	0.00024	CbGpPWpGaD
Remifentanil—OPRK1—Signaling by GPCR—IL2—breast cancer	4.39e-05	0.00024	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—TERT—breast cancer	4.37e-05	0.000239	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—NFKBIA—breast cancer	4.34e-05	0.000237	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—SMAD4—breast cancer	4.32e-05	0.000236	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—NOTCH1—breast cancer	4.3e-05	0.000234	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—IGF1R—breast cancer	4.29e-05	0.000234	CbGpPWpGaD
Remifentanil—OPRM1—GPCR downstream signaling—CXCL8—breast cancer	4.27e-05	0.000233	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—FGFR1—breast cancer	4.25e-05	0.000232	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—HES1—breast cancer	4.22e-05	0.00023	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—PIK3CG—breast cancer	4.2e-05	0.000229	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—KIT—breast cancer	4.2e-05	0.000229	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—APC—breast cancer	4.2e-05	0.000229	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—PLA2G4A—breast cancer	4.19e-05	0.000229	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—NCOR1—breast cancer	4.19e-05	0.000229	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—HIF1A—breast cancer	4.18e-05	0.000228	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—EGF—breast cancer	4.15e-05	0.000227	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—CSF2—breast cancer	4.15e-05	0.000226	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—FGF1—breast cancer	4.15e-05	0.000226	CbGpPWpGaD
Remifentanil—OPRM1—Signaling by GPCR—RAF1—breast cancer	4.14e-05	0.000226	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—NRG1—breast cancer	4.12e-05	0.000225	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—H2AFX—breast cancer	4.09e-05	0.000223	CbGpPWpGaD
Remifentanil—OPRM1—GPCR downstream signaling—IL2—breast cancer	4.08e-05	0.000223	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—LEP—breast cancer	4.08e-05	0.000223	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—E2F1—breast cancer	4.06e-05	0.000221	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—CAV1—breast cancer	4.05e-05	0.000221	CbGpPWpGaD
Remifentanil—OPRM1—Signaling by GPCR—PIK3CB—breast cancer	4.04e-05	0.00022	CbGpPWpGaD
Remifentanil—OPRD1—Signaling by GPCR—MAPK3—breast cancer	4.02e-05	0.00022	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—KDR—breast cancer	4e-05	0.000218	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—BRAF—breast cancer	3.95e-05	0.000216	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—SPP1—breast cancer	3.9e-05	0.000213	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—ESR1—breast cancer	3.9e-05	0.000213	CbGpPWpGaD
Remifentanil—OPRM1—Signaling by GPCR—CXCL8—breast cancer	3.88e-05	0.000212	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—ERBB3—breast cancer	3.86e-05	0.00021	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—FGFR2—breast cancer	3.85e-05	0.00021	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—FN1—breast cancer	3.85e-05	0.00021	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—IGF1—breast cancer	3.85e-05	0.00021	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—AKT2—breast cancer	3.84e-05	0.00021	CbGpPWpGaD
Remifentanil—OPRD1—Signaling by GPCR—EGFR—breast cancer	3.83e-05	0.000209	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—NFKBIA—breast cancer	3.8e-05	0.000208	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—NOTCH1—breast cancer	3.77e-05	0.000206	CbGpPWpGaD
Remifentanil—OPRM1—Signaling by GPCR—IL2—breast cancer	3.71e-05	0.000202	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—TERT—breast cancer	3.7e-05	0.000202	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—PIK3CD—breast cancer	3.69e-05	0.000202	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—PIK3CG—breast cancer	3.68e-05	0.000201	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—KIT—breast cancer	3.68e-05	0.000201	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—APC—breast cancer	3.68e-05	0.000201	CbGpPWpGaD
Remifentanil—OPRD1—GPCR downstream signaling—PIK3CA—breast cancer	3.66e-05	0.0002	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—SERPINE1—breast cancer	3.65e-05	0.000199	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—EGF—breast cancer	3.64e-05	0.000199	CbGpPWpGaD
Remifentanil—OPRD1—Signaling by GPCR—KRAS—breast cancer	3.62e-05	0.000197	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—FGFR1—breast cancer	3.59e-05	0.000196	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—HIF1A—breast cancer	3.53e-05	0.000193	CbGpPWpGaD
Remifentanil—OPRK1—Signaling by GPCR—MAPK3—breast cancer	3.53e-05	0.000193	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—NOS3—breast cancer	3.49e-05	0.00019	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—BRAF—breast cancer	3.46e-05	0.000189	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—LEP—breast cancer	3.45e-05	0.000188	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—CAV1—breast cancer	3.42e-05	0.000187	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—KDR—breast cancer	3.38e-05	0.000184	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—IGF1—breast cancer	3.37e-05	0.000184	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—AKT2—breast cancer	3.37e-05	0.000184	CbGpPWpGaD
Remifentanil—OPRK1—Signaling by GPCR—EGFR—breast cancer	3.36e-05	0.000183	CbGpPWpGaD
Remifentanil—OPRD1—Signaling by GPCR—PIK3CA—breast cancer	3.32e-05	0.000181	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—MDM2—breast cancer	3.31e-05	0.000181	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—RAF1—breast cancer	3.3e-05	0.00018	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—ESR1—breast cancer	3.29e-05	0.00018	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—RELA—breast cancer	3.28e-05	0.000179	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—ERBB2—breast cancer	3.26e-05	0.000178	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—FN1—breast cancer	3.25e-05	0.000178	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—PIK3CD—breast cancer	3.24e-05	0.000177	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—PIK3CB—breast cancer	3.22e-05	0.000176	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—MTOR—breast cancer	3.22e-05	0.000176	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—NFKBIA—breast cancer	3.22e-05	0.000175	CbGpPWpGaD
Remifentanil—OPRK1—GPCR downstream signaling—PIK3CA—breast cancer	3.21e-05	0.000175	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—SERPINE1—breast cancer	3.2e-05	0.000175	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—NOTCH1—breast cancer	3.18e-05	0.000174	CbGpPWpGaD
Remifentanil—OPRK1—Signaling by GPCR—KRAS—breast cancer	3.17e-05	0.000173	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—KIT—breast cancer	3.11e-05	0.00017	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—PIK3CG—breast cancer	3.11e-05	0.00017	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—APC—breast cancer	3.11e-05	0.00017	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—CXCL8—breast cancer	3.09e-05	0.000169	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—EGF—breast cancer	3.08e-05	0.000168	CbGpPWpGaD
Remifentanil—OPRD1—Signaling by GPCR—HRAS—breast cancer	3.07e-05	0.000168	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—NOS3—breast cancer	3.06e-05	0.000167	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—CDKN1B—breast cancer	3.02e-05	0.000165	CbGpPWpGaD
Remifentanil—OPRD1—GPCR downstream signaling—AKT1—breast cancer	2.99e-05	0.000163	CbGpPWpGaD
Remifentanil—OPRM1—Signaling by GPCR—MAPK3—breast cancer	2.98e-05	0.000163	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—CASP3—breast cancer	2.96e-05	0.000162	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—IL2—breast cancer	2.96e-05	0.000161	CbGpPWpGaD
Remifentanil—OPRD1—Signaling by GPCR—IL6—breast cancer	2.94e-05	0.000161	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—BRAF—breast cancer	2.93e-05	0.00016	CbGpPWpGaD
Remifentanil—OPRK1—Signaling by GPCR—PIK3CA—breast cancer	2.91e-05	0.000159	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—MDM2—breast cancer	2.9e-05	0.000158	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—RAF1—breast cancer	2.89e-05	0.000158	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—CCND1—breast cancer	2.88e-05	0.000157	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—RELA—breast cancer	2.88e-05	0.000157	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—JUN—breast cancer	2.88e-05	0.000157	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—ERBB2—breast cancer	2.86e-05	0.000156	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—CTNNB1—breast cancer	2.85e-05	0.000156	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—IGF1—breast cancer	2.85e-05	0.000156	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—AKT2—breast cancer	2.85e-05	0.000155	CbGpPWpGaD
Remifentanil—OPRM1—Signaling by GPCR—EGFR—breast cancer	2.84e-05	0.000155	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—PIK3CB—breast cancer	2.82e-05	0.000154	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—MTOR—breast cancer	2.82e-05	0.000154	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—MMP9—breast cancer	2.8e-05	0.000153	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—CDKN1A—breast cancer	2.79e-05	0.000152	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—PTEN—breast cancer	2.78e-05	0.000152	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—PIK3CD—breast cancer	2.74e-05	0.000149	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—MAPK8—breast cancer	2.72e-05	0.000149	CbGpPWpGaD
Remifentanil—OPRD1—Signaling by GPCR—AKT1—breast cancer	2.71e-05	0.000148	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—CXCL8—breast cancer	2.71e-05	0.000148	CbGpPWpGaD
Remifentanil—OPRM1—GPCR downstream signaling—PIK3CA—breast cancer	2.71e-05	0.000148	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—SERPINE1—breast cancer	2.71e-05	0.000148	CbGpPWpGaD
Remifentanil—OPRK1—Signaling by GPCR—HRAS—breast cancer	2.7e-05	0.000147	CbGpPWpGaD
Remifentanil—OPRM1—Signaling by GPCR—KRAS—breast cancer	2.68e-05	0.000146	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—CDKN1B—breast cancer	2.65e-05	0.000145	CbGpPWpGaD
Remifentanil—OPRK1—GPCR downstream signaling—AKT1—breast cancer	2.62e-05	0.000143	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—CASP3—breast cancer	2.6e-05	0.000142	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—IL2—breast cancer	2.59e-05	0.000141	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—NOS3—breast cancer	2.58e-05	0.000141	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—SRC—breast cancer	2.58e-05	0.000141	CbGpPWpGaD
Remifentanil—OPRK1—Signaling by GPCR—IL6—breast cancer	2.58e-05	0.000141	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—CCND1—breast cancer	2.53e-05	0.000138	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—JUN—breast cancer	2.52e-05	0.000138	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—VEGFA—breast cancer	2.51e-05	0.000137	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—CTNNB1—breast cancer	2.5e-05	0.000137	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—STAT3—breast cancer	2.49e-05	0.000136	CbGpPWpGaD
Remifentanil—OPRM1—Signaling by GPCR—PIK3CA—breast cancer	2.46e-05	0.000134	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—MMP9—breast cancer	2.45e-05	0.000134	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—MDM2—breast cancer	2.45e-05	0.000134	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—CDKN1A—breast cancer	2.45e-05	0.000133	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—RAF1—breast cancer	2.44e-05	0.000133	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—PTEN—breast cancer	2.44e-05	0.000133	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—RELA—breast cancer	2.43e-05	0.000133	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—ERBB2—breast cancer	2.42e-05	0.000132	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—MAPK8—breast cancer	2.39e-05	0.00013	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—MTOR—breast cancer	2.39e-05	0.00013	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—PIK3CB—breast cancer	2.39e-05	0.00013	CbGpPWpGaD
Remifentanil—OPRK1—Signaling by GPCR—AKT1—breast cancer	2.38e-05	0.00013	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—MAPK3—breast cancer	2.38e-05	0.00013	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—MYC—breast cancer	2.31e-05	0.000126	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—TGFB1—breast cancer	2.31e-05	0.000126	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—CXCL8—breast cancer	2.29e-05	0.000125	CbGpPWpGaD
Remifentanil—OPRM1—Signaling by GPCR—HRAS—breast cancer	2.28e-05	0.000124	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—SRC—breast cancer	2.26e-05	0.000123	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—EGFR—breast cancer	2.26e-05	0.000123	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—CDKN1B—breast cancer	2.24e-05	0.000122	CbGpPWpGaD
Remifentanil—OPRM1—GPCR downstream signaling—AKT1—breast cancer	2.22e-05	0.000121	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—VEGFA—breast cancer	2.2e-05	0.00012	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—CASP3—breast cancer	2.19e-05	0.00012	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—IL2—breast cancer	2.19e-05	0.00012	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—STAT3—breast cancer	2.18e-05	0.000119	CbGpPWpGaD
Remifentanil—OPRM1—Signaling by GPCR—IL6—breast cancer	2.18e-05	0.000119	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—KRAS—breast cancer	2.14e-05	0.000117	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—CCND1—breast cancer	2.14e-05	0.000117	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—JUN—breast cancer	2.13e-05	0.000116	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—CTNNB1—breast cancer	2.12e-05	0.000115	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—MAPK3—breast cancer	2.08e-05	0.000114	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—MMP9—breast cancer	2.07e-05	0.000113	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—CDKN1A—breast cancer	2.07e-05	0.000113	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—PTEN—breast cancer	2.06e-05	0.000113	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—MYC—breast cancer	2.03e-05	0.000111	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—TGFB1—breast cancer	2.02e-05	0.00011	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—MAPK8—breast cancer	2.02e-05	0.00011	CbGpPWpGaD
Remifentanil—OPRM1—Signaling by GPCR—AKT1—breast cancer	2.01e-05	0.00011	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—EGFR—breast cancer	1.98e-05	0.000108	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—PIK3CA—breast cancer	1.96e-05	0.000107	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—SRC—breast cancer	1.91e-05	0.000104	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—TP53—breast cancer	1.9e-05	0.000104	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—KRAS—breast cancer	1.87e-05	0.000102	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—VEGFA—breast cancer	1.86e-05	0.000102	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—STAT3—breast cancer	1.84e-05	0.000101	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—HRAS—breast cancer	1.82e-05	9.91e-05	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—MAPK3—breast cancer	1.76e-05	9.61e-05	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—IL6—breast cancer	1.74e-05	9.48e-05	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—PIK3CA—breast cancer	1.72e-05	9.39e-05	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—MYC—breast cancer	1.71e-05	9.35e-05	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—TGFB1—breast cancer	1.71e-05	9.33e-05	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—EGFR—breast cancer	1.68e-05	9.15e-05	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—TP53—breast cancer	1.66e-05	9.09e-05	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—AKT1—breast cancer	1.6e-05	8.75e-05	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—HRAS—breast cancer	1.59e-05	8.69e-05	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—KRAS—breast cancer	1.58e-05	8.64e-05	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—IL6—breast cancer	1.52e-05	8.32e-05	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—PIK3CA—breast cancer	1.45e-05	7.94e-05	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—TP53—breast cancer	1.41e-05	7.68e-05	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—AKT1—breast cancer	1.41e-05	7.67e-05	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—HRAS—breast cancer	1.35e-05	7.34e-05	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—IL6—breast cancer	1.29e-05	7.03e-05	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—AKT1—breast cancer	1.19e-05	6.48e-05	CbGpPWpGaD
